Clinical guide for diagnosis and care of children and adolescents with post-infectious bronchiolitis obliterans, 2009;Guía clínica para el diagnóstico y cuidado de niños/adolescentes con bronquiolitis obliterante post-infecciosa, 2009

Revista Chilena de Enfermedades Respiratorias

Volumn 25, Issue 3, 2009, Pages 141-163

  Vega Briceño, Luis E ^a   Daniel, Zenteno A ^a   Abara, Selim ^a   Álvarez, Cecilia ^a   Arancibia, Juan Carlos ^a   Arce, José Domingo ^a   Barja, Salesa ^a   Bertrand, Pablo ^a   Boza, Lina ^a   Campos, Carolina ^a   Castro Rodríguez, José A ^a   Caussade, Solange ^a   Chateau, Bernardita ^a   Contreras, Ilse ^a   Durán, Fabiola ^a   Espinosa, Tatiana ^a   Fernández, Patricia ^a   Fielbaum, Oscar ^a   García, Marianela ^a   González, Ramiro ^a   Hernández, Jury ^a   Herrera, Patricio ^a   Iñiguez, Fernando ^a   Jakubson, Leticia ^a   Kogan, Ricardo ^a   Koppmann, Andres ^a   Largo, Isabel ^a   Lezana, Viviana ^a   Linares, Marcela ^a   Montes, Soledad ^a   Muñoz, Constanza ^a   Paiva, Rebeca ^a   Parra, Genoveva ^a   Pérez, María Angélica ^a   Perillán, José A ^a   Prado, Francisco ^a   Sánchez, Ignacio ^a   Silva, Junia ^a   Strickler, Alexis ^a   Valdez, Isabel ^a   Wegner, Adriana ^a   Wevar, María Elena ^a   Zamorano, Alejandra ^a   Zúñiga, Sergio ^a   Rodríguez, Claudia ^a   Rosales, Alejandra ^a   Salinas, Pamela ^a   Ciudad, Daniel ^a   Contreras, Stefanie ^a   Meyer, Rodolfo ^a   Puppo, Homero ^a   Silva, Richard ^a   Vera, Roberto ^a   Villarroel, Gregory ^a   Canales, María Cristina ^a   Castro, Margaret ^a   more..

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Adolescents; Bronchiolitis obliterans; Children; Clinical guides; Diagnosis; Treatment

Indexed keywords

EID: 70450184690     PISSN: 07175698     EISSN: 07177348     Source Type: Journal    
DOI: None     Document Type: Article

References (187)

1. ABRAMS S A. Chronic Pulmonary Insufficiency in children and its effects on growth and development. J Nutr 2001; 131: 938s-41s.
2. AMBROSINO N., VAGHEGGINI G. Noninvasive positive pressure ventilation in the acute care setting: where are we? Eur Respir J 2008; 31: 874-86.
3. AMERICAN ACADEMY OF PEDIATRICS, Committee on Hospital Care and Section on Critical Care and Society of Critical Care Medicine, Pediatric Section Admission Criteria Task Force. Guidelines for Developing Admission and Discharge Policies for the Pediatric Intensive Care Unit. Pediatrics 1999; 103; 840-2.
4. AMERICAN THORACIC SOCIETY, European Respiratory Society. ATS/ERS statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006; 173: 1390-413.
5. ANDREASSON B., JONSON B., KORNFALT R., NORDMARK E., SANDSTROM S. Long-term effects of physical exercise on working capacity and pulmonary function in cystic fibrosis. Acta Paediatr Scand 1987; 76: 70-5.
6. ARCE J. Secuelas post-infección por adenovirus: evaluación por tomografía computada. Rev Chil Radiol 2002; 8: 154-66.
7. ASHER M.I., PARDY R.L., COATES A.L., THOMAS E., MACKLEM P T. The effect of inspiratory muscle training in patients with cystic fibrosis. Am Rev Respir Dis 1982; 126; 855-9.
8. ATS/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 2003; 167: 211-77.
9. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7.
10. AVITAL A., SPRINGER CH, BAR-YISHAY E., GODFREY S. Adenosine, methacholine, and exercise in children with asthma or paediatric chronic obstructive pulmonary disease. Thorax 1995; 50: 511-6.
11. BALFOUR-LYNN I M. Domiciliary Oxygen for Children. Pediatr Clin North Am 2009; 56: 275-96.
12. BALFOUR-LYNN I.M., PRIMHAK R.A., SHAW B N. Home oxygen for children: who, how and when? Thorax 2005; 60: 76-81.
13. BAR-OR O. Pediatric sports medicine for the practitioner. New York, NY: McGraw-Hill, 1983.
14. BARJA S. Nutrición en enfermedades crónicas respiratorias infantiles. Capítulo 42. En: Enfoque clínico de las Enfermedades Respiratorias del Niño. Autores: Sánchez I. y Prado F. Ediciones Universidad Católica de Chile. Enero 2007.
15. BARKER A. Bronchiectasis. N Engl J Med 2002; 346: 1383-93.
16. BATTISTI A., TASSAUX D., JANSSENS J.P., MICHOTTE J.B., JABER S., JOLLIET P. Performance characteristics of 10 home mechanical ventilators in pressure-support mode: a comparative bench study. Chest 2005; 127: 1784-92.
17. BECROFT D M. Bronchiolitis obliterans, bronchiectasis, and other sequelae of adenovirus type 21 infection in young children. J Clin Pathol 1971; 24: 72-82.
18. BISGAARD H., KLUG B. Lung function measurement in awake young children. Eur Respir J 1995; 8: 2067-75.
19. BOSA V.L., MELLO E.D., MOCELIN H.T., BENEDETTI F.J., FISCHER G B. Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr (Rio J) 2008; 84: 323-30.
20. BRAGGION C., CORNACCHIA M., MIANO A., SCHENA F., VERLATO G., MASTELLA G. Exercise tolerance and effects of training in young patients with cystic fibrosis and mild airway obstruction. Pediatr Pulmonol 1989; 7: 145-52.
21. BRITISH THORACIC SOCIETY. Statement Pulmonary Rehabilitation. Thorax 2001; 56: 827-34.
22. CARLSON B.A., SWENSEN S.J., O'CONNELL E.J., EDELL E S. High-resolution computed tomography for obliterative bronchiolitis. Mayo Clin Proc 1993; 68: 307-8.
23. CASTRO-RODRÍGUEZ J.A., DASZENIES C., GARCÍA M., MEYER R., GONZALES R. Adenovirus pneumonia in infants and factors for developing bronchiolitis obliterans: a 5-year follow-up. Pediatr Pulmonol 2006; 41: 947-53.
24. CAZZATO S., POLETTI V., BERNARDI F., LORONI L., BERTELLI L., COLONNA S., et al. Airway inflammation and lung function decline in childhood postinfectious bronchiolitis obliterans. Pediatric Pulmonology 2008; 43: 381-90.
25. CERNY F. Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis. Phys Ther 1989; 69: 633-39.
26. COLBY T V. Bronchiolitis. Pathologic considerations. Am J Clin Pathol 1998; 109: 101-9.
27. COULTAS D.B., SAMET J.M., BUTLER C. Bronchiolitis obliterans due to Mycoplasma pneumoniae. West J Med 1986; 144: 471-4.
28. COLOM A.J., TEPER A.M., VOLLMER W.M., DIETTE G B. Risk factors for the development of bronchiolitis obliterans in children with bronchiolitis. Thorax 2006; 61: 503-6.
29. COLOM A.J., MAFFEY A.F., NAVARRA F., TEPER A. Pulmonary function in children with post-viral chronic pulmonary disease (PCPD). In: ATS International Conference 2002; Atlanta; p. A159 (Abstract).
30. COLOM A.J., NAVARRA F., KOFMAN C., TEPER A. Respiratory mechanics in children with post-viral chronic pulmonary disease (PCPD). Am J Respir Crit Care Med 2002; 163: A159. (Abstract).
31. COLOM A.J., TEPER A M. Postinfectious bronchiolitis obliterans. Arch Argent Pediatr 2009; 107: 160-7.
32. Consenso de oxígenoterapia domiciliaria en pediatría. Arch Argent Pediatr 2005; 103: 535-44.
33. COPLEY S.J., PADLEY S P. High-resolution CT of paediatric lung disease. Eur Radiol 2001; 11: 2564-75.
34. COSTA C.L., SPILBORGHS G.M., MARTINS M.A., SALDIVA P.H., MAUAD T. Nitric acid-induced bronchiolitis in rats mimics childhood Bronchiolitis obliterans. Respiration 2005; 72: 642-9.
35. COSTA M.L., STEIN R.T., BAUER M.E., MACHA-DO D.C., JONES M.H., BERTOTTO C., et al. Levels of Th1 and Th2 cytokines in children with post-infectious bronchiolitis obliterans. Ann Trop Paediatr 2005; 25: 261-6.
36. CHAN P.W., MURIDAN R., DEBRUYNE J A. Bronchiolitis obliterans in children: clinical profile and diagnosis. Respirology 2000; 5: 369-75.
37. CHANG A., MASEL J., MASTERS B. Post-infectious bronchiolitis obliterans: clinical, radiological and pulmonary function sequelae. Pediatr Radiol 1998; 28: 23-9.
38. CHIH-YUNG CHIU, KIN-SUN WONG, YHU-CHERING HUANG, TZOU-YIEN LIN. Bronchiolitis obliterans in children: Clinical presentation, therapy and long-term follow-up. J Paediatrics and Child Health 2008; 44: 129-33.
39. CHUANG Y.Y., CHIU C.H., WONG K.S., HUANG J.G., HUANG Y.C., CHANG L.Y., LIN T Y. Severe adenovirus infection in children. J Microbiol Immunol Infect 2003; 36: 37-40.
40. CHOI S.J., CHOI B.K., KIM H.J., LEE S.H., CHOI S.H., PARK S.J., et al. Lateral decubitus HRCT: a simple technique to replace expiratory CT in children with air trapping. Pediatr Radiol 2002; 32: 179-82.
41. DE MEER G., HEEDERIK D., POSTMA D S. Bronchial responsiveness to adenosine 59-monophosphate (AMP) and methacholine differ in their relationship with airway allergy and baseline FEV1. Am J Respir Crit Care Med 2002; 165: 327-31.
42. DELLON E., DONALDSON S., JOHNSON R., DAVIS S. Safety and tolerability of inhales hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol 2008; 43: 1100-6.
43. DONALDSON S. Hydrator therapies for cystic fibrosis lung disease. Pediatr Pulmonol 2008; 43: S18-S23.
44. DOSANJH A. Unilateral bronchiolitis obliterans: a case report. Clin Pediatr (Phila) 1992; 31: 319-20.
45. DUMAS C., SKAFF C., JUST J., TOUNIAN P., FONTAINE J.L., GRIMFELD A., et al. Body composition of children with chronic Lung Disease. Pediatr Pulmonol 1997; 16: 174-6.
46. EDLUND L.D., FRENCH R.W., HERBST J.J., RUTTENBURG H.D., RUHLING R.O., ADAMS T D. Effects of a swimming program on children with cystic fibrosis. Am J Dis Child 1986; 140: 80-3.
47. ENG P.A., MORTON J., DOUGLASS J.A., RIEDLER J., WILSON J., ROBERTSON C F. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Pediatr Pulmonol 1996; 21: 77-83.
48. EPLER G R. Bronchiolar disorders with airflow obstruction. Curr Opin Pulm Med 1996; 2: 134-40.
49. ESSOURI S., CHEVRET L., DURAND P., HAAS V., FAUROUX B., DEVICTOR D. Noninvasive positive pressure ventilation: five years of experience in a pediatric intensive care unit. Pediatr Crit Care Med 2006; 7: 329-34.
50. FAUROUX B., LOFASO F. Domiciliary non-invasive ventilation in children. Rev Mal Respir 2005; 22: 289-303.
51. FAUROUX B., LOFASO F. Non-invasive mechanical ventilation: when to start for what benefit? Thorax 2005; 60: 979-80.
52. FAROUX B., PIGET J., POLKEY M., ISABEY D., CLEMENT A., LOFASO F. In vivo physiologic comparison of two ventilators used for domiciliary ventilation in children with cystic fibrosis. Crit Care Med 2001; 29: 2097-105.
53. FISHER G.B., TEPER A.M., COLOM A J. Acute viral bronchiolitis and its sequel in developing countries. Paediatrics Respiratory Rev 2002; 3: 298-302.
54. FORTENBERRY J.D., DEL TORO J., JEFFERSON L.S., EVEY L., HAASE D. Management of pediatric acute hipoxemic respiratory insufficiency with bilevel positive pressure (BIPAP) nasal mask ventilation. Chest 1995; 108: 1059-64.
55. FULLMER J.J., FAN L.L., DISHOP M.K., RODGERS C., KRANCE R. Successful treatment of bronchiolitis obliterans in a bone marrow transplant patient with tumor necrosis factor alpha blockade. Pediatrics 2005; 116: 767-70.
56. GAILLARD E. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003; 47: 215-20.
57. GARROD R. Role of physiotherapy in the management of chronic lung diseases: an overwiew od systematic reviews. Resp Med 2007; 101: 249-56.
58. GEIGER R., STRASAK A., TREML B., GASSER K., KLEINSASSER A., FISCHER V., et al. Six-minute walk test in children and adolescents. J Pediatr 2007; 150: 395-9.
59. GERHARDT S.G., MCDYER J.F., GIRGIS R.E., CON-TE J.V., YANG S.C., ORENS J B. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003; 168: 121-5.
60. GIBSON P G. Sputum induction in children. Eur Respir J 2002; 20: 44s-46s.
61. GIBSON P.G., HENRY R.L., THOMAS P. Noninvasive assessment of airway inflammation in children: induced sputum, exhaled nitric oxide, and breath condensate. Eur Respir J 2000; 16: 1008-15.
62. GIRARDET J., VIOLA S. Nutrition and severe chronic respiratory diseases: pathophysiologic mechanisms. Pediatr Pulmonol 2001; s23: 20-21.
63. GODGFREY S., SPRINGER C., NOVISKI N., MAAYAN CH, AVITAL A. Exercise but not methacholine differenciates astma from chronic lung disease in children. Thorax 1991; 46: 488-92.
64. GODFREY S. Pulmonary hemorrhage/hemoptysis in children. Pediatr Pulmonol 2004; 37: 476-84.
65. Grupo de trabajo de la SEPAR. Pruebas de ejercicio cardiopulmonar. Arch Bronconeumología 2001; 37: 247-68.
66. Guía de Organización y Funcionamiento de Unidades de Pacientes Críticos Pediátricos (UPC). Rama de Intensivos Pediátricos, Sociedad Chilena de Pediatría. Ministerio de Salud de Chile. 2006.
67. HACKEN N. Bronchiectasis. Clin Evid 2006; 15: 1-9.
68. HANSELL D M. Small airways diseases: detection and insights with computed tomography. Eur Respir J 2001; 17: 1294-313.
69. HAGGERTY M.C., JONES P. Clinically meaningful outcomes in patients with chronic obtructive pulmonary disease. Am J Med 2004; 117 (Suppl 12A): 49S-59S.
70. HARDY K A. Childhood bronchiolitis obliterant. In: Epler GR, Editor. Disease of Bronchioles. New York: Raven Press Ltd 1994, p 415-26.
71. HARDY K.A., SCHIDLOW D.V., ZAERI N. Obliterative bronchiolitis in children. Chest 1988; 93: 460-6.
72. HESS D R. The evidence for noninvasive positive-pressure ventilation in the care of patients in acute respiratory failure: a systematic review of the literature. Respir Care 2004; 49: 810-29.
73. HIRSCHHEIMER M., SILVA P.S., GIUDICI R., CARRILHO M., MAUAD T., ISHIDA M. Simultaneous viral infection and childhood bronchiolitis obliterans. Braz J Infect Dis 2002; 6: 146-8.
74. HO S.A., BALL R., MORRISON L.J., BROWNLEE K.G., CONWAY S P. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol 2004; 38: 82-7.
75. HODGES I.G., MILNER A.D., GROGGINS R.C., STOKES G M. Causes and management of bronchiolitis with chronic obstructive features. Arch Dis Child 1982; 57: 495-9.
76. HODSON M., MADDEN B., STEVEN M., TSANG V., YACOUB M. Non-invasive mechanical ventilation for cystic fibrosis patients-a potential bridge to transplantation. Eur Respir J 1991; 4: 524-7.
77. HUMAN ENERGY REQUIREMENTS. Report of a join FAO/WHO/UNU Expert Consultation. Rome, 17-24 October, 2001. FAO, Food and Nutrition Technical Report Series.
78. JAIMOVICH D. Admission and discharge guidelines for the pediatric patient requiring intermediate care. Crit Care Med 2004; 32: 1215-18.
79. JENSEN S.P., LYNCH D.A., BROWN K.K., WENZEL S.E., NEWELL J D. High-resolution CT features of severe asthma and bronchiolitis obliterans. Clin Radiol 2002; 57: 1078-85.
80. JONES M.H., PITREZ P.M., STEIN R T. Post-Infectious Bronchiolitis Obliterans. Pediatr Pulmonol Suppl 2004; 26: 64-5.
81. KALENGA M. Lung growth and development during experimental malnutrition. Pediatr Pulmonol 1997; s16: 165-6.
82. KARADAG B. Non-Cistyc-Fibrosis Bronchiectasis in Children: A Persistent problem in developing countries. Respiration 2005; 72: 233-38.
83. KEENS T.G., KRASTINS I.R., WANNAMAKER E.M., LEVISON H., CROZIER D.N., BRYAN A C. Ventilatory muscle endurance training in normal subject end patients in cystic fibrosis. Am Rev Respir Dis 1977; 116: 853.
84. KESSON. Respiratory virus infection. Paediatric Respiratory Rev 2007; 8: 240-248.
85. KIM C., KIM S., KIM J., KOH Y., COHEN A., DETERDING R.R., et al. Bronchiolitis obliterans in the 1990s in Korea and the United States. Chest 2001; 120: 1101-6.
86. KIM M.J., LEE K Y. Bronchiolitis obliterans in children with Stevens-Johnson syndrome: follow-up with high resolution CT. Pediatr Radiol 1996; 26: 22-5.
87. KIM D.K., YOO Y., YU J., CHOI S.H., KOH Y Y. Bronchial responsiveness to methacholine and adenosine 5́-monophosphate (AMP) in young children with post-infectious bronchiolitis obliterans. Acta Paediatrica 2006; 95: 56-61.
88. KING P. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs 2007; 67: 965-74.
89. KLUG B., BISGAARD H. Measurement of lung function in awake 2-4 years old asthmatic children during methacholine challenge and acute asthma. Pediatr Pulmonol 1996; 21: 290-300.
90. KOH Y Y. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest 2007; 131: 1454-60.
91. KOH Y.Y., JUNG D.E., KOH J.Y., KIM J.Y., YOO Y., KIM C K. Bronchoalveolar cellularity and interleukin-8 levels in measles bronchiolitis obliterans. Chest 2007; 131: 1454-60.
92. KRASINSKI K. Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome. Pediatr Infect Dis 1985; 4: 250-7.
93. KURLAND G., MICHELSON P. Bronchiolitis obliterans in children. Pediatr Pulmonol 2005; 39: 193-208.
94. LARAYA-CUASAY L.R., DEFOREST A., HUFF D., LISCHNER H., HUANG N N. Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis 1977; 116: 617-25.
95. LEITH D., BRADLEY M. Ventilatory muscle strength and endurance training. J Appl Physiol 1976; 41: 508.
96. LELLOUCHE F., MAGGIORE S.M., DEYE N., TAILLÉ S., PIGEOT J., HARF A., et al. Effect of the humidification device on the work of breathing during noninvasive ventilation. Intensive Care Med 2002; 28: 1582-9.
97. LEONG M.A., NACHAJON R., RUCHELLI E., ALLEN J L. Bronchitis obliterans due to Mycoplasma pneumonia. Pediatr Pulmonol 1997; 23: 375-81.
98. LI A.M., YIN J., AU J.T., SO H.K., TSANG T., WONG E., et al. Standard reference for the 6-minute walk test in healthy children aged 7 to 16 years. Am J Respir Crit Care Med 2007; 176: 174-80.
99. LINARES M., MEYER R., SOTO G. Evaluación de la respuesta broncodilatadora en pacientes secuelados de adenovirus. Rev Chil Pediatr 2004; 75: S37-S44.
100. LOUGHLIN G., HEIGEN H. Respiratory disease in children, diagnosis and management. Barsky D.L., Stallings V A. Nutritional Management in Pediatric Pulmonary disease. Edit. Williams and Wilkins, 1° Ed, 1994: 813-28.
101. LOBO AL, GUARDIANO M., NUNES T., AZEVEDO I., VAZ L G. Pos-infectious bronchiolitis obliterans in children. Rev Port Pneumol 2007; 13: 495-509.
102. LÖTTERS F., VAN TOL B., KWAKKEL G., GOSSELINK R. Effects of controlled inspiratory muscle training in patients with COPD: a metaanalysis. Eur Respir J 2002; 20: 570-6.
103. LYNCH D.A., HAY T., NEWELL J.D. Jr, DIVGI V.D., FAN L L. Pediatric diffuse lung disease: diagnosis and classification using high-resolution CT. AJR Am J Roentgenol 1999; 173: 713-8.
104. MAFFEY A.F., COLOM A.J., KOFMAN C.D., VIDAUMETA S.M., TEPER A M. Longitudinal Study of pulmonary function in infants with postviral chronic pulmonary disease. Am J Respir Crit Care Med 1996; 4: A153 (Abstract).
105. MAGDE S., BRYON M. A model for transition from pediatric to adult care in cystic fibrosis. J Pediatr Nurs 2002; 17: 283-8.
106. MANCUSO M., PACCHIONI D., RUFFINI E., CAVALLO A., FILOSSO P., VIALE A., et al. Successful bilateral lung volume reduction in a child with emphysema from bronchiolitis obliterans. J Thorac Cardiovasc Surg 2004; 128: 645-7.
107. MAROSTICA P. Non-Cistyc-Fibrosis Bronchiectasis. A Perspective from South America. Paed Resp Rev 2006; 7: 275-80.
108. MASSIE R., ARMSTRONG D. Bronchiectasis and bronchiolitis obliterans post respiratory syncytial virus infection: think again. J Paediatr Child Health 1999; 35: 497-8.
109. MATTIELLO R., SARRIA E.E., STEIN R., FISCHER G.B., MOCELIN H.T., BARRETO S.S., et al. Functional capacity assessment during exercise in children and adolescents with post-infectious bronchiolitis obliterans. J Pediatr (Rio J) 2008; 84: 337-43.
110. MAUAD T., DOLHNIKOFF M; São Paulo Bronchiolitis Obliterans Study Group. Histology of childhood bronchiolitis obliterans. Pediatr Pulmonol 2002; 33: 466-74.
111. MAUAD T., VAN SCHADEWIJK A., SCHRUMPF J., et al. Lymphocytic inflammation in childhood bronchiolitis obliterans. Pediatr Pulmonol 2004; 38: 233-9.
112. MEDINA A., PRIETO S., REY M., CONCHA A., MENÉNDEZ S., CRESPO M. Aplicación de la ventilación no invasiva en una Unidad de Cuidados Intensivos Pediátricos. An Pediatr (Barc) 2005; 62: 13-9.
113. MEHTA S., HILL N S. Noninvasive Ventilation. Am J Respir Crit Care Med 2001; 163: 540-77.
114. MEYER B., DE BLIC J., PARIENTE D., LAMOUR C., BENOIST M.R., NEZELOF C., et al. Bronchiolitis obliterans: investigation and diagnosis. Ann Pediatr (Paris) 1983; 30: 351-5.
115. MILLER A. Guidelines for the management of spontaneous pneumothorax. Brit Med J 1993; 307: 114-6.
116. MINSAL. Estadísticas nutricionales, Plan Nacional de Alimentación Complementaria (PNAC) del prematuro extremo y displasia broncopulmonar del prematuro: Guías clínicas MINSAL. www.minsal.cl
117. MISTCHENKO A.S., DIEZ R.A., MARIANI A.L., ROBALDO J., MAFFEY A.F., BAYLEY-BUSTA-MANTE G., et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. J Pediatr 1994; 124: 714-20.
118. MISTCHENKO A.S., KOCH E R.R., KAJON A.E., TIBALDI F., MAFFEY A.F., DIEZ R A. Lymphocyte subsets and cytokines in adenoviral infection in children. Acta Paediatr 1998; 87: 933-9.
119. MOCELIN H., FISCHER G., IRIAR K., CUNHA L. Evaluación clínica y funcional de niños con bronquiolitis obliterante post-infecciosa con seguimiento a largo plazo. Rev Chil Pediatr 2004; 75 (Supl): S12-7.
120. MOONNUMAKAL S.P., FAN L L. Bronchiolitis obliterans in children. Current Opinion in Pediatrics 2008, 20: 272-8.
121. MURTAGH P., GIUBERGIA V., VIALE D., BAUER G., PENA H G. Lower respiratory infections by adenovirus in children. Clinical features and risk factors for bronchiolitis obliterans and mortality. Pediatr Pulmonol 2009; 44: 450-6.
122. MUTHALITAS K. Improvement in health status following bonchopulmonary hygiene physical therapy in patients with bronchiectasis. Resp Med 2008; 102: 1140-44.
123. NICOLAI T. Pediatric Bronchoscopy. Pediatric Pulmonol 2001; 31: 150-64.
124. NIXON P.A., JOSWIAK M.L., FRICKER F J. A sixminute walk test for assessing exercise tolerance in severely ill children. J Pediatr 1996; 129: 362-6.
125. NIXON P.A., ORENSTEIN D.M., KELSEY S.F., DOERSHUK C F. The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med 1992; 327: 1785-8.
126. Norma Programa Nacional de Oxígeno Ambulatorio. Minsal, 2003.
127. NORREEGAARD O. Non-invasive ventilation in acute respiratory failure in children. En: Non-invasive respiratory Support. Simonds AK. Third edition, Edward Arnold (Publishers) Ltd. 2007; 257-73.
128. NORREGAARD O. Noninvasive ventilation in children. Eur Respir J 2002; 20: 1332-42.
129. NORZILA M.Z., AZIZI B.H., NORRASHIDAH A.W., YEOH N.M., DENG C T. Home oxygen therapy for children with chronic lung diseases. Med J Malaysia 2001; 56: 151-7.
130. O'DONNELL A. Bronchiectasis. Chest 2008; 134: 815-23.
131. O'LONE E. Spontaneous pneumothorax in children: when is invasive treatment indicated? Pediatr Pulmonol 2008; 43: 41-6.
132. ORENSTEIN D.M., HOVELL M.F., MULVIHILL M., KEATING K.K., HOFSTETTER C.R., KELSEY S., et al. Strength vs aerobic training in children with cystic fibrosis: a randomized controlled trial. Chest 2004; 126: 1204-14.
133. PADLEY S.P., ADLER B.D., HANSELL D.M., MÜLLER N L. Bronchiolitis obliterans: high resolution CT findings and correlation with pulmonary function tests. Clin Radiol 1993; 47: 236-40.
134. PAIVA R., CAMPOS C., SALINAS P., PRADO F. Asistencia ventilatoria no invasiva: Guía para el manejo de pacientes con insuficiencia respiratoria aguda. Neumol Pediatr 2008; 3 (supp1): 45-53.
135. PENN C.C., LIU C. Bronchiolitis following infection in adults and children. Clin Chest Med 1993; 14: 645-54.
136. PEREIRA G.R., BAUMGART S., BENNETT M.J., STALLINGS V.A., GEORGIEFF M.K., HAMOSH M., et al. Use of high-fat formula for premature infants with bronchopulmonary dysplasia: Metabolic, pulmonary, and nutritional studies. J Pediatr 1994; 124: 605-11.
137. PÉREZ M.J., KOGAN R., MAGGI L., MENDOZA C. Seguimiento clínico y factores de riesgo en niños con enfermedades respiratorias por adenovirus. Rev Chil Ped 2007; 78: 261-67.
138. PRABHU M.B., BARBER D., COCKCROFT D W. Bronchiolitis obliterans and Mycoplasma pneumonia. Respir Med 1991; 85: 535-7.
139. RICARD J.D., DREYFUSS D., SAUMON G. Ventilator-induced lung injury. Eur Respir J 2003; 42 Suppl: 2S-9S.
140. RIES A.L., BAULDOFF G.S., CASABURI R., MAHLER D.A., ROCHESTER C.L., HERRERÍAS C; Pulmonary Rehabilitation, Join ACCP/AACVPR Evidence-Based Clinica Practice Guidelines. Chest 2007; 131 (5 Suppl): 4S-42S.
141. ROEBUCK D. Hemoptysis and bronchial artery embolization in children. Ped Resp Rev 2008; 9: 95-104.
142. RUSZNIERZ G., COCIGLIO R., PIERINI J., MALATINI M., WALKER A. Arch Argent Pediatr 2007; 105: 216-20.
143. SÁNCHEZ I., VALENZUELA A., BERTRAND P. Apoyo ventilatorio domiciliario en niños con insuficiencia respiratoria crónica. Experiencia clínica. Rev Chil Pediatr 2002; 73: 51-5.
144. SAWYER E.H., CLANTON T L. Improved pulmonary function and exercise tolerance with inspiratory muscle conditioning in children with cystic fibrosis. Chest 1993; 104: 1490-7.
145. SAWYER S., ROSIER M., PHELAN P., BOWES G. The self-image of adolescents with cystic fibrosis. J Adolesc Health 1995; 16: 204-8.
146. SCHLESINGER C., VEERARAGHAVAN S., KOSS M N. Constructive (obliterative) bronchiolitis. Curr Opin Pulm Med 1998; 4: 288-93.
147. SCHELLHASE D E. Pediatric Flexible airway endoscopy. Curr Opin Pediatr 2002; 14: 327-33.
148. SCHRAMEL F. Currents aspects of spontaneous pneumothorax. Eur Resp J 1997; 10: 1372-79.
149. SIBTAIN N.A., PADLEY S P. HRCT in small and large airways diseases. Eur Radiol 2004; 14 Suppl 4: L31-43.
150. SIMILA S., LINNA O., LLANNING P., HEIKKINEN E., ALA-HOUHALA M. Chronic lung damage caused by adenovirus type 7: a ten-year follow-up study. Chest 1981; 80: 127-31.
151. SILVA J., PUPPO H., VARGAS D., GONZÁLEZ R., PAVÓN D., GIRARDI G. Entrenamiento muscular inspiratorio en niños secuelados por adenovirus. Rev Chil Enfer Respir 1999; 15: 239.
152. SIMONDS A K. Recent advances in respiratory care for neuromuscular disease. Chest 2006; 130: 1879-86.
153. SIMONDS A K. Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality. Semin Respir Crit Care Med 2007; 28: 342-54.
154. SLY P.D., SOTO-QUIROS M.E., LANDAU L.I., HUDSON I., NEWTON-JOHN H. Factors predisposing to abnormal pulmonary function after adenovirus type 7 pneumonia. Arch Dis Child 1984; 59: 935-9.
155. SMITH K.J., FAN L L. Insights into post-infectious bronchiolitis obliterans in children. Thorax 2006; 61: 462-63.
156. SOLWAY S., BROOKS D., LACASSE Y., THOMAS S. A qualitative systemic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001; 119: 256-70.
157. SOTO G. Tomografía computada de alta resolución en niños con daño pulmonar crónico por adenovirus: caracterización y correlación con función pulmonar. Rev Chil Radiol 2002; 8: 149-53.
158. SURI R., MARSHALL L.J., WALLIS C., METCALFE C., SHUTE J.K., BUSH A. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol 2003; 35: 309-13.
159. SZEINBERG A., MARCOTTE J.E., ROIZIN H., MINDORFF C., ENGLAND S., TABACHNIK E., et al. Normal values of maximal inspiratory and expiratory pressures with a portable apparatus in children, adolescents, and young adults. Pediatr Pulmonol 1987; 3: 255-8.
160. TEPER A.M., FISCHER G., JONES M H. Respiratory sequelae of viral diseases: from diagnosis to treatment. J Pediatr (Rio J) 2002; 78 Suppl 2: S187-94.
161. TEPER A.M., KOFMAN C.D., MAFFEY A.F., VIDARRUETA S M. Lung function in infants with chronic pulmonary disease after severe adenoviral illness. J Pediatr 1999; 134: 730-3.
162. THYS F., LIISTRO G., DOZIN O., MARION E., RODENSTEIN D. Determinants of FiO2 with oxygen supplementation during noninvasive two-level positive pressure ventilation. Eur Respir J 2002; 19: 653-7.
163. TIMOTHY B., OP 'T.H. "Physiology of Ventilatory Support". En: Egan PD, Ed. Egan's Fundamentals of Respiratory Care 2003; 963-1002.
164. TOUSSAINT M., CHATWIN M., SOUDON P. Mechanical ventilation in Duchenne patients with chronic respiratory insufficiency: clinical implications of 20 years published experience. Chron Respir Dis 2007; 4: 167-77.
165. VAN AALDEREN W.M., KRAAN J., KOETER G.H., VAN DER SCHANS C P. Inspiratory muscle training in patients with cystic fibrosis. Respir Med 2001; 95: 31-6.
166. VAN DEN BERG J.W., SLEBOS D.J., POSTMA DS, DIJKHUIZEN B., KOËTER G.H., TIMENS W., et al. Feasibility of sputum induction in lung transplant recipients. Clin Transplant 2004; 18: 605-12.
167. VEGA-BRICEÑO L.E., ABARCA V.K., SÁNCHEZ D I. Vacuna influenza en niños: estado del arte. Rev Chilena Infectol 2006; 23: 164-9.
168. VEGA-BRICEÑO L.E., GUIRALDES C.E., SÁNCHEZ I. Cystic fibrosis: facing patient transition from the pediatrician to the internist. Rev Méd Chile 2006; 134: 365-71.
169. VERLEDEN G.M., VANAUDENAERDE B.M., DUPONT L.J., VAN RAEMDONCK D.E. Azithromycin. Am J Respir Crit Care Med 2006; 174: 566-70.
170. VILARÓ J. Prueba de marcha de 6 minutos. En: Burgos F., Casan P. Manual SEPAR de Procedimientos, modulo 4. Barcelona, España: Publicaciones Permayer 2004, 100-14.
171. VILCHEZ R.A., DAUBER J., KUSNE S. Infectious etiology of bronchiolitis obliterans: the respiratory viruses connection-myth or reality?. Am J Transplant 2003; 3: 245-9.
172. WAITCHES G.M., STERN E J. High-resolution CT of peripheral airways diseases. Radiol Clin North Am 2002; 40: 21-9.
173. WARD S., CHATWIN M., HEATHER S., SIMONDS A K. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005; 60: 1019-24.
174. WHITFORD H., WALTERS E.H., LEVVEY B., KOTSIMBOS T., ORSIDA B., WARD C., et al. Addition of inhaled corticosteroids to systemic immuno-suppression after lung transplantation: a double-blind, placebo-controlled trial. Transplantation 2002; 73: 1793-9.
175. WOHL M.E., CHERNICK V. State of the art: bronchiolitis. Am Rev Resp Dis 1978; 118: 759-81.
176. WRIGHT J.L., CAGLE P., CHURG A., COLBY T.V., MYERS J. Diseases of the small airways. Am Rev Respir Dis 1992; 146: 240-62.
177. YALÇIN E., DOGRU D., HALILOGLU M., OZÇELIK U., KIPER N., GÖÇMEN A. Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors. Respiration 2003; 70: 371-5.
178. YÁÑEZ L.J., YUNGE M., EMILFORK M., LAPADULA M., ALCÁNTARA A., FERNÁNDEZ C., et al. A prospective, randomized, controlled trial of noninvasive ventilation in pediatric acute respiratory failure. Pediatr Crit Care Med 2008; 9: 484-9.
179. YATES B., MURPHY D.M., FORREST I.A., WARD C., RUTHERFORD R.M., FISCHER A.J., et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005; 172: 772-5.
180. YOO Y., KIM D.K., CHOI S.H., KIM C.K., KOH Y Y. Methacholine and adenosine 5́-monophosphate challenges in children with post-infectious bronchiolitis obliterans. Eur Respir J 2006; 27: 36-41.
181. ZACK J., JACOBS C.P., KEENAN P.M., HARNEY K., WOODS E.R., COLIN A.A., et al. Perspectives of patients with cystic fibrosis on preventive counselling and transition to adult care. Pediatr Pulmonol 2003; 36: 376-83.
182. ZENTENO D., PUPPO H., GONZÁLEZ R., KOGAN R. Test de Marcha de 6 minutos en Pediatría. Neumol Pediatr 2007; 2: 109-14.
183. ZENTENO D., PUPPO H., GONZÁLEZ R., PAVON D., VERA R., TORRES R., et al. Test de marcha de seis minutos en niños con bronquiolitis obliterante postviral. Correlación con espirometría. Rev Chil Enfer Respir 2008; 24: 15-9.
184. ZENTENO D., PUPPO H., VERA R., TORRES R., CHUNG-YANG K., PRADO F., et al. Guías de rehabilitación para niños con enfermedades respiratorias crónicas. Neumol Pediatr 2008; 3 (supl 1): 25-33.
185. ZHANG L., IRION K., KOZAKEWICH H., REID L., CAMARGO J.J., DA SILVA PORTO N., et al. Clinical course of postinfectious bronchiolitis obliterans. Pediatr Pulmonol 2000; 29: 341-50.
186. ZHANG L., MENDOZA-SASSI R.A., WAINWRIGHT C., KLASSEN T P. Nebulized hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2008; 8: CD006458.
187. ZHANG L., SILVA F A. Bronchiolitis obliterans in children. J Pediatr (Rio J) 2000; 76: 185-92.